As from April 2013 my Journey in Investing is to create Retirement Income for Life till 80 years old for two over market cycles of Bull and Bear.

Welcome to Ministry of Wealth!

This blog is authored by an old multi-bagger blue chips stock picker uncle from HDB heartland!

"The market is not your mother. It consists of tough men and women who look for ways to take money away from you instead of pouring milk into your mouth." - Dr. Alexander Elder

"For the things we have to learn before we can do them, we learn by doing them." - Aristotle

It is here where I share with you how I did it! FREE Education in stock market wisdom.

Think Investing as Tug of War - Read more? Click and scroll down



Important Notice and Attention: If you are looking for such ideas; here is the wrong blog to visit.

Value Investing
Dividend/Income Investing
Technical Analysis and Charting
Stock Tips

Wednesday, 12 November 2014

Biosensors' Q2 earnings fall 56% to US$4.9m

By
MEDICAL devices company Biosensors International reported a net profit of US$4.9 million for the three months ended Sept 30, 56 per cent lower than the US$11.3 million a year ago.

This was due to selling prices coming down across various regions for its key heart stent product. The company also cited an impact from reduced licensing revenue, and increased investment in clinical and registry trial expenses.

Overall revenue fell 10 per cent, from US$83 million to US$74.8 million, but cost of sales increased 9 per cent to US$20.9 million.

"The company experienced sustained softness in its overall business that was more severe than originally expected," new CEO Jose "Pepe" Calle Gordo told analysts at a call on Wednesday.

"While we continue to think Biosensors has many strengths, we do acknowledge we need to improve our performance, focus on improving operational efficiency, and enhancing the effectiveness of our execution."


One main reason for the company's underperformance is that its China business remains weak, Mr Gordo said. This is due to prices coming down, weak sentiment and the anti-corruption campaign by the Chinese government, he added.

Biosensors has appointed a medical industry veteran to review its China strategy, Mr Gordo said.

The counter closed up a cent to S$0.635 before results were out.

1 comment:

  1. Read? Biosensors - Sold $1.21 ROC 22.1%

    Round 2 on 8 November 2010 but since then I have not play the buy back game for Biosensors for the next round.

    Me not a diehard Gamer. LOL!




    ReplyDelete

Related Posts with Thumbnails